Hints and tips:
...Artificial intelligence has surpassed the limits of scientific knowledge by predicting the shape of almost every known protein, a breakthrough that will significantly reduce the time required to make biological...
...Hassabis hopes the lab will use AI beyond AlphaFold2 to predict complex biological phenomena....
...Meat production is moving out of abattoirs and into laboratories....
...Since Prof McNaughton moved to King’s in 2013, his laboratory has been looking for chemicals that block the activity of HCN2....
...Joining the faculty in 1995, she stayed for 18 years, working on biological data whenever she could....
...He founded Dolby Laboratories in London in 1965 but 10 years later moved the company to San Francisco, where he had grown up....
...The goal is to make machines that feel and behave more like biological than mechanical systems, and give additional powers to the wearer....
...Roger Perlmutter, president of MSD Research Laboratories, said the reason for basing the operations in the UK was “pretty straightforward”....
...The Swiss development will add to the excitement over bioprinting, which is the bespoke 3D printing of biological material....
...“Our concept for biological security needs to be broadened.”...
...“What we now know is that cancer cells are constantly turning over and dying,” explains Chris Boshoff, head of immuno-oncology at Pfizer....
...“UK Biobank has amassed an enormous amount of securely stored health, lifestyle, medical and biological data,” said Sir Rory Collins, Biobank’s leader....
...Lack of commercial or public funding meant it languished on a laboratory shelf until the emergency in west Africa prompted Merck & Co to acquire and develop it....
...The German company, still controlled by descendants of Friedrich Jacob Merck, its 17th century founder, said on Wednesday it was dropping its two divisional brands — Serono pharmaceuticals and Millipore laboratory...
...“It’s clearly a very significant deal financially, but more important is the potential of the science and the potential together to be a broader leader in the immuno-oncology space,” he added....
...This involves removing T cells from the patient’s body and modifying them in a laboratory with chimeric antigen receptors....
...Analysts estimate that annual peak sales for immuno-oncology drugs will hit between $35bn and $40bn within the next decade....
...Based just north of Chicago, Illinois, Hospira was spun out of Abbott Laboratories, the US healthcare group, in 2004 and has gone on to become the world’s largest producer of generic injectable medicines...
...The idea is to restock pipelines with exciting new biological compounds that treat conditions such as cancer....
...“The whole immuno-oncology area is exploding,” says John LaMattina, former head of research and development for Pfizer....
...Some of its most brilliant engineers, working at the pioneering Google Eggs laboratory, will shortly unveil a range of solutions designed to slow and eventually erase the biological clock....
...While Sovaldi may be an exceptional case, there is a growing number of expensive speciality medicines emerging from laboratories that collectively promise to put further stress on budgets....
...In fact, the real cause of the inflammation is a deficiency of biological oxidants....
...MABs and other biological drugs have provided an important shot in the arm for the survival of an industry dominated by chemicals until just a few years ago....
...Many patents on new compounds fail during subsequent laboratory tests and clinical trials in humans to meet the safety and efficacy requirements to become authorised medicines....
International Edition